Auwaerter on Infectious Diseases

 
 

  • Cases Are Up, Mask Use Is Down -- Let's Reverse That   With COVID-19 cases spiking after states began relaxing restrictions, a strong recommendation from physicians for using masks is the most important thing that can be done, says Dr Paul Auwaerter.
  • 'Thinnest Threads of Evidence' for COVID-19 Treatments   Potential treatments for COVID-19 may be emerging, but the landscape remains 'bleak,' says Dr Paul Auwaerter.
  • Coronaviruses: What We Know Now   With the arrival of the new coronavirus, 2019-nCoV, there is much to learn. What do we know about it already, and how can we prepare for its possible spread?
  • Infectious Diseases in 2020: 5 Areas of Concern   Dr Paul Auwaerter discusses advances made in infectious diseases in 2019 and looks ahead at concerns for the new year.
  • Auwaerter's Highlights From IDWeek 2019   Dr Paul Auwaerter discusses topics of interest from IDWeek 2019.
  • Lyme Testing Gets Fast and Easy   Dr Paul Auwaerter comments on the newly approved, modified two-tier approach for diagnosing Lyme disease.
  • Will This Be the Holy Grail for Sepsis?   An effective intervention for severe sepsis and septic shock can't come soon enough.
  • Severe Malaria: Only One Drug Option Remains   Patient with severe malaria? Call the CDC, rather than the pharmacy, to obtain artesunate.
  • 'Zombie Deer Disease' Spreading; Watch What You Eat   Dr Paul Auwaerter discusses the threat to humans from 'zombie deer disease,' more accurately known as 'chronic wasting disease.'
  • Baloxavir's Place in the Treatment of Flu   We are learning more about baloxavir and how it differs from existing antiviral drugs for treating influenza. Paul Auwaerter describes the drug's potential advantages.
  • Are Showerheads Causing Chronic Lung Infections?   An ecologic study reveals the US hotspots for showerhead biofilms contaminated with mycobacteria and a geographical correlation with nontuberculous mycobacterial lung disease.
  • Oral Antibiotics for Infective Endocarditis: Time to Switch?   The standard of care for endocarditis for many years has been IV antibiotics, even though many patients don't complete the full treatment. Would oral antibiotics work just as well?
  • Fever of Unknown Origin in an Adult-- Periodic Fever Syndromes?   Dr Paul Auwaerter highlights syndromes associated with recurrent fever in adults.
  • A Call for a Lyme Disease Vaccine   With the increase in vector-borne disease, we need more than an ounce of prevention. What we really need is a vaccine for Lyme disease.
  • Consulting an ID Specialist Saves Lives and Money   The value in consulting ID in the management of serious infections is revealed by this recent analysis.
  • Influenza and MRSA Pneumonia   Dr Paul Auwaerter discusses the antimicrobial options for postinfluenza MRSA pneumonia, and makes the case for a universal flu vaccine.
  • A New Way ID Care Is Valued   Dr Paul Auwaerter urges infectious diseases clinicians to review and incorporate into their practice two new CPT codes for prolonged services without direct face-to-face patient contact.
  • California Contagion: How to Control Severe Hepatitis A   Dr Paul Auwaerter discusses California's hepatitis A outbreak and the challenges of testing to avoid false-positives.
  • CMV Disease in the Non-immunosuppressed ICU Patient   Is CMV just a bystander or is it a contributor to critical illness in non-immunosuppressed ICU patients? A new study provides a few answers and raises new questions.
  • Add Legionella to Your Differential Diagnosis for Pneumonia   Don't forget to consider Legionella as a cause of hospital-acquired pneumonia. It's more common and deadlier than some may realize.